fb tracking

Product Recalls: March 13, 2024 – April 17, 2024

Health Letter, May 2024

Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.

For Class 1 recalls, there is a potential for serious injury or death.

For Class 2 recalls, there is a potential for serious adverse events but a lower chance of the drug causing serious injury or death than in a Class 1 recall.



diltiazem hydrochloride extended-release capsules, 120 mg, twice-a-day dosage, 100 capsules per bottle. Manufactured for: Glenmark Pharmaceuticals Inc. Lot #: 17230304, exp. date: 12/31/2024.

divalproex sodium extended-release tablets, 250 mg, 100 tablets. Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Lot #: AR210704, exp. date: 04/2024; Lot #: AR210706, exp. date: 04/2024; Lot #: AR210707, exp. date: 04/2024; Lot #: AR210708, exp. date: 04/2024; Lot #: AR210709, exp. date: 04/2024.

febuxostat tablets, 40 or 80 mg, 30 tablets per bottle. Manufactured for: Northstar Rx LLC. Manufactured by: Sun Pharmaceutical Industries Limited. Lot #: DNE0865A or DNE0866A, exp. date: 06/30/2025; Lot #: DNE0894A, exp. date: 07/31/2025.

isotretinoin capsules, 40 mg, 30-count 3×10 blister packs per carton. Manufactured for: Teva Pharmaceuticals USA, Inc. Lot #: 100044259, exp. date: 06/30/2025.

lansoprazole delayed-release capsules, 15 mg, 14 capsules per bottle. Manufactured by: Natco Pharma Limited. Lot #: 411988, exp. date: 05/31/2025.

rifampin capsules, 300 mg, 30-count bottles. Manufactured for: Lupin Pharmaceuticals, Inc. Manufactured by: Lupin Limited. Lot #: A201064, exp. date: March 2024.

telmisartan tablets, 40 mg, 30 tablets per bottle. Manufactured by: Micro Labs Limited. Lot #: SFBG024 or SFBG025, exp. date: 05/31/2024.

Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets, triphasic regimen, packaged in carton containing 3 blister cards, 28 tablets each. Teva Pharmaceuticals USA, INC. Lot #: 100039678, exp date: 04/31/2024; Lot #: 100038111 or 100042277, exp. date: 07/31/2024.

For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.


For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.